List Title | APhA DrugInfoLine

Pharmacogenomics Corner

SORT BY: Most Recent Most Viewed

February 22, 2017

Pharmacogenetic testing may improve quality of care of nursing home residents

READ

PREVIEW
Residents of nursing homes that performed pharmacogenetic testing had reductions in moderate to severe pain compared with those residing in nursing homes that did not do this type of personalized...
January 17, 2017

Blueprint for pharmacogenomic competencies for pharmacists and students

READ

PREVIEW
A new commentary published in JAPhA highlights the evolving role of pharmacists in pharmacogenomics. The field requires pharmacists to be competent in numerous areas, such as basic...
November 29, 2016

Many people have CYP gene variations associated with severe drug interactions

READ

PREVIEW
A retrospective analysis of more than 22,000 patients who underwent pharmacogenetic testing for polymorphisms of five cytochrome (CYP) isoenzymes showed that the majority of patients had multiple...
October 18, 2016

Race/ethnicity and genetic ancestry of black patients with asthma do not predict inhaled corticosteroid response

READ

PREVIEW
Responsiveness to inhaled corticosteroids (ICSs) was associated with measures of lung function and asthma control and not related to self-reported race/ethnicity or African ancestry, according to...
May 3, 2016

Pharmacogenomics testing is cost effective

READ

PREVIEW
A pharmacoeconomic analysis concluded that one-time genetic testing is cost effective for preventing adverse drug reactions (ADRs) over a patient’s lifetime.

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.